Ann: Admedus Receives FDA Clearance for CardioCel 3D, page-39

back in with a small parcel - is this a real break or another false start?
Never doubted the quality of Cardiocel but had strong doubts about the company's direction and financial control and never liked Rodne's style - maybe things are now different so I'll give it another go. My previous trading foray was successful so I hope I can repeat it.
Advances in Cardiocel underpin the basic support for the stock but it hasn't yet taken the surgical world by storm and I'm not sure why sales are not already a whole lot better?
Upcoming podcast will set the immediate trend. IMO if it's just fluff then back to recent movements if there's any real progress on the vaccine front then there will be the inevitable boost but wouldn't expect it to be anything dramatic given the glacial progress in the vaccine area by all companies.
Let's see what the rest of the week holds...